Yuki Ohmori, Eiji Hishinuma, Yuma Suzuki, Akiko Ueda, Caroline Mwendwa Kijogi, Tomoki Nakayoshi, Akifumi Oda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, et al. Comprehensive functional characterization of rare and known CYP2E1 allelic variants identified in a Japanese population. Biochemical Pharmacology. 2025. 117396-117396
Reema Saleous, Eiji Hishinuma, Zeina N. Al-Mahayri, Akiko Ueda, Yuma Suzuki, Mohammad A. Ghattas, Radwa E. Mahgoub, Masahiro Hiratsuka, Bassam R. Ali. Evaluation of the functional impact of rare CYP2C19 missense variants identified in understudied Populations: An Integrated in silico and in vitro analysis. Biochemical Pharmacology. 2025. 117350-117350
Masato Takase, Naoki Nakaya, Mana Kogure, Rieko Hatanaka, Kumi Nakaya, Ippei Chiba, Sayuri Tokioka, Kotaro Nochioka, Tomohiro Nakamura, Naho Tsuchiya, et al. Association of circulating metabolites and polygenic risk score with incident type 2 diabetes: a prospective community-based cohort study. Cardiovascular diabetology. 2025. 24. 1. 335-335
Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma, Shinpei Kawaoka, Naomi Matsukawa, Yuki Kasahara, Kota Ouchi, Hiroo Imai, Ken Saijo, Keigo Komine, et al. Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025. 26. 15. 7528-7528
Yuu Miyauchi, Haruna Koba, Madoka Sawai, Hisao Kansui, Shinji Takechi, Eiji Hishinuma, Naomi Matsukawa, Masahiro Hiratsuka, Peter I Mackenzie, Yuji Ishii. Disulfide bond-mediated stabilization of the oligomers of UDP-glucuronosyltransferase 2B7. The Journal of biological chemistry. 2025. 301. 9. 110502-110502
2022/03 - Biocrates Life Sciences AG Biocrates publishing Editor’s Choice Award Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer